Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Pender, Michael P ^a,b   Csurhes, Peter A ^a,c   Pfluger, Casey M M ^a,c   Burrows, Scott R ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; BIOSYNTHESIS; CELL SEPARATION; EPSTEIN BARR VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS;

EID: 79960889385     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-95     Document Type: Article

References (38)

1. Ascherio A, Munger KL. Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010, 5:271-277. 10.1007/s11481-010-9201-3, 20369303.
2. Santiago O, Gutierrez J, Sorlozano A, de Dios Luna J, Villegas E, Fernandez O. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis 2010, 29:857-866. 10.1007/s10096-010-0940-0, 20428908.
3. Pender MP. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist 2011, 17:351-367. 10.1177/1073858410381531, 21075971.
4. Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002, 3:940-943. 10.1038/ni835, 12244309.
5. Van Noort JM, Bajramovic JJ, Plomp AC, van Stipdonk MJB. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis. J Neuroimmunol 2000, 105:46-57. 10.1016/S0165-5728(00)00181-8, 10713363.
6. Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003, 24:584-588. 10.1016/j.it.2003.09.005, 14596882.
7. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007, 204:2899-2912. 10.1084/jem.20071030, 2118531, 17984305.
8. Krone B, Grange JM. Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?. Autoimmune Dis 2010, 2011:708750. 3010623, 21197482.
9. Pender MP. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimmun Rev 2009, 8:563-568. 10.1016/j.autrev.2009.01.017, 19254880.
10. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007, 25:587-617. 10.1146/annurev.immunol.25.022106.141553, 17378764.
11. Lünemann JD, Tintoré M, Messmer B, Strowig T, Rovira A, Perkal H, Caballero E, Münz C, Montalban X, Comabella M. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010, 67:159-169. 10.1002/ana.21886, 2848293, 20225269.
12. Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 2008, 131:1712-1721. 10.1093/brain/awn108, 18550621.
13. Gronen F, Ruprecht K, Weissbrich B, Klinker E, Kroner A, Hofstetter HH, Rieckmann P. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls. J Neuroimmunol 2006, 180:185-192. 10.1016/j.jneuroim.2006.08.008, 17023054.
14. Höllsberg P, Hansen HJ, Haahr S. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 2003, 132:137-143. 10.1046/j.1365-2249.2003.02114.x, 1808679, 12653848.
15. Pender MP, Csurhes PA, Lenarczyk A, Pfluger CMM, Burrows SR. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80:498-505. 10.1136/jnnp.2008.161018, 2663364, 19015225.
16. Pender MP, Csurhes PA, Pfluger CMM, Burrows SR. CD8 T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosis. J Neurol Neurosurg Psychiatry 2011,
17. Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Büssow K, Sommer N, Hemmer B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005, 115:1352-1360. 1077174, 15841210.
18. Craig JC, Hawkins SA, Swallow MW, Lyttle JA, Patterson VH, Merrett JD, Haire M. Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis. Clin Exp Immunol 1985, 61:548-555. 1577275, 3000660.
19. Lindsey JW, Hatfield LM. Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivity. J Neuroimmunol 2010, 229:238-242. 10.1016/j.jneuroim.2010.08.009, 20826010.
20. Li F, Linan MJ, Stein MC, Faustman DL. Reduced expression of peptide-loaded HLA class I molecules on multiple sclerosis lymphocytes. Ann Neurol 1995, 38:147-154. 10.1002/ana.410380205, 7654061.
21. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria". Ann Neurol 2005, 58:840-846. 10.1002/ana.20703, 16283615.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
23. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005, 64:1144-1151. 10.1212/01.WNL.0000156155.19270.F8, 15824338.
24. Kouwenhoven M, Teleshova N, Özenci V, Press R, Link H. Monocytes in multiple sclerosis: phenotype and cytokine profile. J Neuroimmunol 2001, 112:197-205. 10.1016/S0165-5728(00)00396-9, 11108949.
25. Gudgeon NH, Taylor GS, Long HM, Haigh TA, Rickinson AB. Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity. J Virol 2005, 79:5477-5488. 10.1128/JVI.79.9.5477-5488.2005, 1082738, 15827162.
26. Reinherz EL, Weiner HL, Hauser SL, Cohen JA, Distaso JA, Schlossman SF. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med 1980, 303:125-129. 10.1056/NEJM198007173030303, 6446039.
27. Bach M-A, Phan-Dinh-Tuy F, Tournier E, Chatenoud L, Bach J-F, Martin C, Degos J-D. Deficit of suppressor T cells in active multiple sclerosis. Lancet 1980, 316:1221-1223.
28. Compston A. Lymphocyte subpopulations in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1983, 46:105-114. 10.1136/jnnp.46.2.105, 1027291, 6221079.
29. Antel JP, Peeples DM, Reder AT, Arnason BGW. Analysis of T regulator cell surface markers and functional properties in multiple sclerosis. J Neuroimmunol 1984, 6:93-103. 10.1016/0165-5728(84)90030-4, 6233299.
30. Thompson AJ, Brazil J, Whelan CA, Martin EA, Hutchinson M, Feighery C. Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse?. J Neurol Neurosurg Psychiatry 1986, 49:905-912. 10.1136/jnnp.49.8.905, 1028952, 2943874.
31. Trotter JL, Clifford DB, McInnis JE, Griffeth RC, Bruns KA, Perlmutter MS, Anderson CB, Collins KG, Banks G, Hicks BC. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis. Ann Neurol 1989, 25:172-178. 10.1002/ana.410250211, 2521993.
32. Kreuzfelder E, Shen G, Bittorf M, Scheiermann N, Thraenhart O, Seidel D, Grosse-Wilde H. Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls. Eur Neurol 1992, 32:190-194. 10.1159/000116820, 1505587.
33. Michałowska-Wender G, Wender M. Mononuclear subsets in the peripheral blood of multiple sclerosis patients in relation to results of brain gadolinium-enhancing imaging. Folia Neuropathol 2006, 44:67-71.
34. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, Chieco-Bianchi L. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995, 1:1279-1283. 10.1038/nm1295-1279, 7489409.
35. Ferreira MAR, Mangino M, Brumme CJ, Zhao ZZ, Medland SE, Wright MJ, Nyholt DR, Gordon S, Campbell M, McEvoy BP, Henders A, Evans DM, Lanchbury JS, Pereyra F, Walker BD, Haas DW, Soranzo N, Spector TD, de Bakker PI, Frazer IH, Montgomery GW, Martin NG. International HIV Controllers Study Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am J Hum Genet 2010, 86:88-92. 10.1016/j.ajhg.2009.12.008, 2801744, 20045101, International HIV Controllers Study.
36. Jabs DA, Arnett FC, Bias WB, Beale MG. Familial abnormalities of lymphocyte function in a large Sjögren's syndrome kindred. J Rheumatol 1986, 13:320-326.
37. Johnston C, Alviggi L, Millward BA, Leslie RDG, Pyke DA, Vergani D. Alterations in T-lymphocyte subpopulations in type 1 diabetes. Exploration of genetic influence in identical twins. Diabetes 1988, 37:1484-1488. 10.2337/diabetes.37.11.1484, 2972575.
38. Johansen M, Elling P, Elling H, Olsson A. A genetic approach to the aetiology of giant cell arteritis: depletion of the CD8+ T-lymphocyte subset in relatives of patients with polymyalgia rheumatica and arteritis temporalis. Clin Exp Rheumatol 1995, 13:745-748.